Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Sero-epidemiological survey of influenza C virus infection in Spain.

Identifieur interne : 000716 ( Main/Exploration ); précédent : 000715; suivant : 000717

Sero-epidemiological survey of influenza C virus infection in Spain.

Auteurs : J C Manuguerra [France] ; C. Hannoun ; M Del C. Sáenz ; E. Villar ; J A Cabezas

Source :

RBID : pubmed:7957798

Descripteurs français

English descriptors

Abstract

From an overall point of view, the epidemiological situation of influenza C virus infections in western Europe is hardly known. In some countries like Spain, no epidemiological survey has been carried out to determine whether influenza C virus does or does not circulate and cause infection in the considered geographical area. We thus decided to perform such a study. A total of 191 serum samples was collected from people (from 1.5 to 80 years old) living in Spain in October 1990. These sera were tested for the presence of antibodies to influenza C virus by hemagglutination-inhibition (HI) tests. Significant HI activity was found in 59.3 to 64.9% of the 191 tested sera and titres ranged from 20 to 320. The high prevalence of antibody as well as the highly significant titres indicate an intense circulation of influenza C virus in Spain. A significant difference was found between children/teenagers and adults.

DOI: 10.1007/BF01717459
PubMed: 7957798


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Sero-epidemiological survey of influenza C virus infection in Spain.</title>
<author>
<name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Centre North-France, Institut Pasteur, Paris.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
<wicri:orgArea>National Influenza Reference Centre North-France, Institut Pasteur</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
</author>
<author>
<name sortKey="Saenz, M Del C" sort="Saenz, M Del C" uniqKey="Saenz M" first="M Del C" last="Sáenz">M Del C. Sáenz</name>
</author>
<author>
<name sortKey="Villar, E" sort="Villar, E" uniqKey="Villar E" first="E" last="Villar">E. Villar</name>
</author>
<author>
<name sortKey="Cabezas, J A" sort="Cabezas, J A" uniqKey="Cabezas J" first="J A" last="Cabezas">J A Cabezas</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1994">1994</date>
<idno type="RBID">pubmed:7957798</idno>
<idno type="pmid">7957798</idno>
<idno type="doi">10.1007/BF01717459</idno>
<idno type="wicri:Area/Main/Corpus">00717</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00717</idno>
<idno type="wicri:Area/Main/Curation">000717</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000717</idno>
<idno type="wicri:Area/Main/Exploration">000717</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Sero-epidemiological survey of influenza C virus infection in Spain.</title>
<author>
<name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name>
<affiliation wicri:level="3">
<nlm:affiliation>National Influenza Reference Centre North-France, Institut Pasteur, Paris.</nlm:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Paris</settlement>
<region type="région" nuts="2">Île-de-France</region>
</placeName>
<wicri:orgArea>National Influenza Reference Centre North-France, Institut Pasteur</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
</author>
<author>
<name sortKey="Saenz, M Del C" sort="Saenz, M Del C" uniqKey="Saenz M" first="M Del C" last="Sáenz">M Del C. Sáenz</name>
</author>
<author>
<name sortKey="Villar, E" sort="Villar, E" uniqKey="Villar E" first="E" last="Villar">E. Villar</name>
</author>
<author>
<name sortKey="Cabezas, J A" sort="Cabezas, J A" uniqKey="Cabezas J" first="J A" last="Cabezas">J A Cabezas</name>
</author>
</analytic>
<series>
<title level="j">European journal of epidemiology</title>
<idno type="ISSN">0393-2990</idno>
<imprint>
<date when="1994" type="published">1994</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent (MeSH)</term>
<term>Adult (MeSH)</term>
<term>Age Distribution (MeSH)</term>
<term>Aged (MeSH)</term>
<term>Aged, 80 and over (MeSH)</term>
<term>Antibodies, Viral (blood)</term>
<term>Child (MeSH)</term>
<term>Child, Preschool (MeSH)</term>
<term>Hemagglutination Inhibition Tests (MeSH)</term>
<term>Hemagglutination Tests (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Infant (MeSH)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenzavirus C (immunology)</term>
<term>Middle Aged (MeSH)</term>
<term>Seroepidemiologic Studies (MeSH)</term>
<term>Spain (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent (MeSH)</term>
<term>Adulte (MeSH)</term>
<term>Adulte d'âge moyen (MeSH)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Enfant (MeSH)</term>
<term>Enfant d'âge préscolaire (MeSH)</term>
<term>Espagne (épidémiologie)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Influenzavirus C (immunologie)</term>
<term>Nourrisson (MeSH)</term>
<term>Répartition par âge (MeSH)</term>
<term>Sujet âgé (MeSH)</term>
<term>Sujet âgé de 80 ans ou plus (MeSH)</term>
<term>Tests d'hémagglutination (MeSH)</term>
<term>Tests d'inhibition de l'hémagglutination (MeSH)</term>
<term>Études séroépidémiologiques (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Influenzavirus C</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza, Human</term>
<term>Influenzavirus C</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Age Distribution</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Hemagglutination Tests</term>
<term>Humans</term>
<term>Infant</term>
<term>Middle Aged</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Humains</term>
<term>Nourrisson</term>
<term>Répartition par âge</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tests d'hémagglutination</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">From an overall point of view, the epidemiological situation of influenza C virus infections in western Europe is hardly known. In some countries like Spain, no epidemiological survey has been carried out to determine whether influenza C virus does or does not circulate and cause infection in the considered geographical area. We thus decided to perform such a study. A total of 191 serum samples was collected from people (from 1.5 to 80 years old) living in Spain in October 1990. These sera were tested for the presence of antibodies to influenza C virus by hemagglutination-inhibition (HI) tests. Significant HI activity was found in 59.3 to 64.9% of the 191 tested sera and titres ranged from 20 to 320. The high prevalence of antibody as well as the highly significant titres indicate an intense circulation of influenza C virus in Spain. A significant difference was found between children/teenagers and adults.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">7957798</PMID>
<DateCompleted>
<Year>1994</Year>
<Month>12</Month>
<Day>21</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>09</Month>
<Day>04</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0393-2990</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>10</Volume>
<Issue>1</Issue>
<PubDate>
<Year>1994</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>European journal of epidemiology</Title>
<ISOAbbreviation>Eur. J. Epidemiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Sero-epidemiological survey of influenza C virus infection in Spain.</ArticleTitle>
<Pagination>
<MedlinePgn>91-4</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>From an overall point of view, the epidemiological situation of influenza C virus infections in western Europe is hardly known. In some countries like Spain, no epidemiological survey has been carried out to determine whether influenza C virus does or does not circulate and cause infection in the considered geographical area. We thus decided to perform such a study. A total of 191 serum samples was collected from people (from 1.5 to 80 years old) living in Spain in October 1990. These sera were tested for the presence of antibodies to influenza C virus by hemagglutination-inhibition (HI) tests. Significant HI activity was found in 59.3 to 64.9% of the 191 tested sera and titres ranged from 20 to 320. The high prevalence of antibody as well as the highly significant titres indicate an intense circulation of influenza C virus in Spain. A significant difference was found between children/teenagers and adults.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Manuguerra</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo>
<Affiliation>National Influenza Reference Centre North-France, Institut Pasteur, Paris.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hannoun</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Sáenz</LastName>
<ForeName>M del C</ForeName>
<Initials>Mdel C</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Villar</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Cabezas</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Eur J Epidemiol</MedlineTA>
<NlmUniqueID>8508062</NlmUniqueID>
<ISSNLinking>0393-2990</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006385" MajorTopicYN="N">Hemagglutination Inhibition Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006386" MajorTopicYN="N">Hemagglutination Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009982" MajorTopicYN="Y">Influenzavirus C</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1994</Year>
<Month>2</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1994</Year>
<Month>2</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1994</Year>
<Month>2</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">7957798</ArticleId>
<ArticleId IdType="doi">10.1007/BF01717459</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Infect. 1992 Jan;24(1):91-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1312564</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1986 Aug;153(1):12-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2943076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Zentralbl Bakteriol Orig A. 1975;231(1-3):47-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1154916</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Immun. 1980 Nov;30(2):500-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7439993</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 1985 Oct 30;146(2):221-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3855244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 1980 Oct;140(10):1295-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7425764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 1968 Mar;87(2):440-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5647870</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 1981 Nov;14(5):516-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7309849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1955 Oct 22;2(4946):992-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13260642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 1987;31(4):337-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3613994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Egypt Public Health Assoc. 1977;52(1):6-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">556274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Virol. 1983 Nov;27(6):502-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6140836</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Lab Clin Med. 1954 Jan;43(1):31-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13118279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 1982;26(7):639-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7132793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 1992 Sep 1;25(1-2):145-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1413991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Soc Exp Biol Med. 1952 Dec;81(3):Unknown</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13037744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Immunol. 1987;31(11):1137-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3502168</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Cabezas, J A" sort="Cabezas, J A" uniqKey="Cabezas J" first="J A" last="Cabezas">J A Cabezas</name>
<name sortKey="Hannoun, C" sort="Hannoun, C" uniqKey="Hannoun C" first="C" last="Hannoun">C. Hannoun</name>
<name sortKey="Saenz, M Del C" sort="Saenz, M Del C" uniqKey="Saenz M" first="M Del C" last="Sáenz">M Del C. Sáenz</name>
<name sortKey="Villar, E" sort="Villar, E" uniqKey="Villar E" first="E" last="Villar">E. Villar</name>
</noCountry>
<country name="France">
<region name="Île-de-France">
<name sortKey="Manuguerra, J C" sort="Manuguerra, J C" uniqKey="Manuguerra J" first="J C" last="Manuguerra">J C Manuguerra</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000716 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000716 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:7957798
   |texte=   Sero-epidemiological survey of influenza C virus infection in Spain.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:7957798" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021